Thomas Lecompte
Overview
Explore the profile of Thomas Lecompte including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
149
Citations
1709
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Gouin-Thibault I, Lecompte T, Lasne D
J Thromb Haemost
. 2025 Mar;
PMID: 40056986
Anti-FXI/FXIa anticoagulants under development include antisense oligonucleotides, monoclonal antibodies and small molecules. They do not require routine monitoring, but knowledge of their impact on coagulation tests is essential in view...
2.
Gouin-Thibault I, Castellucci L, Connors J, Hardy M, Mansour A, Siguret V, et al.
J Thromb Haemost
. 2025 Feb;
PMID: 39984159
Background: Unfractionated heparin (UFH) remains the anticoagulant of choice in critically ill patients. However, its laboratory monitoring and clinical management are particularly challenging. Objectives: Our objective was to describe current...
3.
Devis L, Arachchillage D, Hardy M, Mansour A, Catry E, Closset M, et al.
Hamostaseologie
. 2025 Feb;
45(1):24-48.
PMID: 39970900
In this review, we aim to highlight the extent of inappropriate hemostasis testing and provide practical guidance on how to prevent it. We will focus on the acute setting, including...
4.
Mansour A, Lecompte T, Nesseler N, Gouin-Thibault I
Anesthesiology
. 2024 Oct;
142(1):242-243.
PMID: 39466060
No abstract available.
5.
Godier A, Lasne D, Pernod G, Blais N, Bonhomme F, Bounes F, et al.
Anaesth Crit Care Pain Med
. 2024 Oct;
:101446.
PMID: 39447869
Background: Any surgical procedure carries a risk for venous thromboembolism (VTE), albeit variable. Improvements in medical and surgical practices and the shortening of care pathways due to the development of...
6.
Gouin-Thibault I, Mansour A, Hardy M, Gueret P, De Maistre E, Siguret V, et al.
TH Open
. 2024 Oct;
8(3):e297-e307.
PMID: 39420916
Nowadays, unfractionated heparin (UFH) use is limited to selected patient groups at high risk of both bleeding and thrombosis (patients in cardiac surgery, in intensive care unit, and patients with...
7.
Bouarroudj H, Hardy M, Lecompte T, Mullier F
Int J Lab Hematol
. 2024 Oct;
47(2):330-335.
PMID: 39415408
No abstract available.
8.
Hardy M, Catry E, Pouplard M, Lecompte T, Mullier F
Res Pract Thromb Haemost
. 2024 Sep;
8(6):102536.
PMID: 39290988
Background: Testing for lupus anticoagulant (LA) is not recommended in case of inflammation as C-reactive protein (CRP) can interfere with the phospholipids present in the activated partial thromboplastin time test...
9.
Khourssaji M, Bareille M, Alberio L, Borgel D, Fouassier M, Bene M, et al.
Thromb Haemost
. 2024 Sep;
PMID: 39260401
Accurate assessment of platelet secretion is essential for the diagnosis of inherited or acquired platelet function disorders and more specifically in identifying δ-storage pool disease. Mepacrine, a fluorescent dye, specifically...
10.
Sinegre T, Abergel A, Lebreton A, Lecompte T
J Thromb Haemost
. 2024 Jul;
22(8):2366-2370.
PMID: 39048270
No abstract available.